4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000173
Chairperson & CEO sold 9,500 shares at an average $587.73 ($5,583,418)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-27 | Sale : show line 2 in the form 10b5-1 | −89 | $582.66 | $51,857 | 333,854 | I |
| 2026-10-27 | Sale : show line 3 in the form 10b5-1 | −807 | $583.94 | $471,243 | 333,047 | I |
| 2026-10-27 | Sale : show line 4 in the form 10b5-1 | −1,417 | $584.83 | $828,703 | 331,630 | I |
| 2026-10-27 | Sale : show line 5 in the form 10b5-1 | −470 | $585.72 | $275,287 | 331,160 | I |
| 2026-10-27 | Sale : show line 6 in the form 10b5-1 | −1,417 | $586.93 | $831,673 | 329,743 | I |
| 2026-10-27 | Sale : show line 7 in the form 10b5-1 | −1,320 | $587.88 | $776,004 | 328,423 | I |
| 2026-10-27 | Sale : show line 8 in the form 10b5-1 | −1,597 | $588.95 | $940,547 | 326,826 | I |
| Open-market sales · 9,500 sh · avg $587.73 · $5,583,418 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-27 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 147,910 | I |
Loading xslF345X06/primarydocument.xml…